← Back
$GALT All transactions

GALECTIN THERAPEUTICS INC

▼ SELL 10b5-1 Plan

$ Value

$60K

Shares

8,500

Price

$7

Filed

Dec 19

Insider

Name

Jamil Khurram

Title

Chief Medical Officer

CIK

0002032345

Roles

Officer

Transaction Details

Transaction Date

2025-12-17

Code

S

Table

Non-Derivative

Ownership

Direct

Equity Swap

No

Shares After

Footnotes

The reported transaction was made pursuant to a Rule 10b5-1 plan adopted by the reporting person on July 15, 2025, as disclosed in the Issuer?s Quarterly Report on Form 10-Q, filed with the SEC on November 14, 2025. | The shares were sold in multiple transactions at prices ranging from $7.00 to $7.11. This amount represents the weighted average sale price of such transactions. The reporting person undertakes to provide full information regarding the number of shares sold at each separate price upon request by the Securities and Exchange Commission, the Issuer, or a security holder of the Issuer. | The options vest as follows: 50,000 on March 11, 2025, with 50,000 scheduled to vest on each of March 11, 2026 and March 11, 2027. | The options vest as follows: 25,000 on each of October 31, 2024, January 31, 2025, April 30, 2025, and July 31, 2025.

Filing Info

Accession No.

0001133416-25-000069

Form Type

4

Issuer CIK

0001133416

Jamil Khurram's History

Date Ticker Type Value
2026-01-16 GALT A $0
2026-01-16 GALT A $0
2026-01-06 GALT $78K
2026-01-05 GALT $99K
2026-01-02 GALT M $0
2026-01-02 GALT $55K
2026-01-01 GALT M $0
2025-12-31 GALT M $10K
2025-12-31 GALT $33K
2025-12-31 GALT M $0

Other Insiders at GALT (90d)

Insider Bought Sold Last
ELDRED KARY $810 2026-02-06
Brem Henry 2026-03-12